Skip to content

Efficacy of calot's triangle local infiltration with ropivacaine for postoperative pain in patients undergoing laparoscopic cholecystectomy: a prospective, randomized, double-blind, controlled, clinical trial

Efficacy of calot's triangle local infiltration with ropivacaine for postoperative pain in patients undergoing laparoscopic cholecystectomy: a prospective, randomized, double-blind, controlled, clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005189
Enrollment
Unknown
Registered
2014-09-07
Start date
2014-09-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

trial group:calot's triangle local infiltration and patient controlled intravenous analgesia with administration of tramadol
control group:patient controlled intravenous analgesia with administration of tramadol

Sponsors

First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who would receive laparoscopic cholecystectomy for any reasons, with 18-65 years old, and with an ASA stage of I-II would be included in this study.

Exclusion criteria

Exclusion criteria: (1) age below 18 years or over 65 years; (2) American Society of Anesthesiologists grade III or greater; (3)Diabetes; (4)chronic pain of any kind other than gallbladder disease; (5)had allergy to the study drugs; (6) had cognitive impairment or communication problems; (7) peptic ulcer; (8) received opioids?NSAID or tranquilizers (treatment for over 1 wk before the cholecystectomy); (9) had a history of alcohol or drug abuse; (10)the operation was converted to an open procedure; (11) gangrenous cholecystitis; (12)Common bile duct exploration or insertion of a T- drain; (13)other invasive procedures; (14) had severe hepatic or renal impairment; (15)if they had postoperative complications(e.g., pyogenic infection).

Design outcomes

Primary

MeasureTime frame
VAS sores of pain while in hospital;NRS scores of pain when 3 and6months after surgery;

Secondary

MeasureTime frame
Times of pressing PCA pump;Total PCIA consumption;Amount of drugs used for remedial analgesia;Incidence of incompletely analgesia after surgery;Incidence of nausea and omitting after surgery whi;Incidence of shoulder pain after surgery while in;the first time to walk after surgery;the first time to void after surgery;Average hospitalization days after surger;

Countries

China

Contacts

Public ContactMin Su
ms89011061@163.com+86 13508302749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026